rollover button

Latest News

The True Patriotic Response to our Growing Tax Crisis

By Claire Buchan Parker – On Tuesday, the Senate Finance Committee is scheduled to hold a hearing that will examine a critical issue impacting the long-term health of the U.S. economy – our international tax system. Dubbed “Love it, Leave It or Reform It!” the committee promises to delve into the specific issue of corporate… Read More

Washington Times: Enabling American companies to compete at home and abroad


Tax reform must reach beyond U.S. borders: Consensus regarding the need to repair our long-broken tax code can be easily found among lawmakers of all stripes — Republican or Democrat — and pro-reform talking points are never in short supply. Unfortunately, this debate only scratches the surface of the reforms needed to our tax code…. Read More

New #Eakinomics Video Explains Why U.S. Companies Move Overseas

AAF logo

As part of the #Eakinomics video series, the American Action Forum (@AAF) today released a new video that explains why U.S. companies decide to move their headquarters overseas after a merger. In the #Eakinomics video, AAF President Douglas Holtz-Eakin explains what a tax inversion is, the reasons driving companies to move their headquarters, and what… Read More

Wall Street Journal: With Businesses Fleeing America, Congress Must Act


By Senator Rob Portman (R-OH): American businesses are heading for the exits to escape the U.S. tax code. Medical device company Medtronic announced recently that it planned to acquire the Ireland-based firm Covidien and relocate headquarters in Dublin, making it the biggest company yet to leave our shores for a more favorable tax climate. It’s… Read More

Wall Street Journal: The Lose-Lose Tax Policy Driving Away U.S. Business


By Michelle Hanlon, accounting professor at MIT’s Sloan School of Management: Apple issued $12 billion of U.S. debt in April, which gave the company a domestic cash infusion that allowed it to keep more earnings overseas. Last month Pfizer attempted to acquire AstraZeneca, a transaction that would have made Pfizer a subsidiary of the U.K.-based company…. Read More